ARTICLE | Top Story
Cor lowers EPS estimates
March 5, 2001 8:00 AM UTC
After the market close on Monday, CORR lowered first quarter and full year EPS and sales estimates for its Integrilin eptifibatide, a peptide inhibitor of the GPIIb/IIIa platelet receptor that is mark...